About TrialScope
TrialScope is a company based in Jersey City (United States) founded in 2012 was acquired by Pharma Intelligence in June 2020. TrialScope has raised $27.97 million across 5 funding rounds from investors including Pharma Intelligence, Bridge Capital and Edison Partners. TrialScope has completed 2 acquisitions, including Clinical Trial Connect and PharmaCM. TrialScope offers products and services including Citeline Clinical, Pink Sheet, TrialScope Disclose, and TrialScope Intelligence. TrialScope operates in a competitive market with competitors including Envision Pharma Group, MetricStream, Octagon Research, Qualio and MasterControl, among others.
- Headquarter Jersey City, United States
-
Sectors
TechnologyHealthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Aero International, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$27.97 M (USD)
in 5 rounds
-
Latest Funding Round
$4 M (USD), Series A
Sep 17, 2018
-
Investors
Pharma Intelligence
& 4 more
-
Employee Count
Not available
-
Investments & Acquisitions
Clinical Trial Connect
& 1 more
-
Acquired by
Pharma Intelligence
(Jun 01, 2020)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of TrialScope
TrialScope offers a comprehensive portfolio of products and services, including Citeline Clinical, Pink Sheet, TrialScope Disclose, and TrialScope Intelligence.
Provides real-time data on global clinical trials and drug pipelines
Delivers analysis of global regulatory policies and trends
Manages clinical trial disclosure and automates reporting
Centralizes global disclosure requirements for compliance
Funding Insights of TrialScope
TrialScope has successfully raised a total of $27.97M across 5 strategic funding rounds. The most recent funding activity was a Series A round of $4 million completed in September 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in TrialScope
TrialScope has secured backing from 5 investors, including venture fund investors. Prominent investors backing the company include Pharma Intelligence, Bridge Capital and Edison Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investment management services are offered by Bridge Capital.
|
Locked | Locked | Locked | |
|
Provider of a growth equity firm for adaptive and personalized plans
|
Locked | Locked | Locked | |
|
Neutral content on stocks and financial markets is provided by Dublin Capital Partners.
|
Locked | Locked | Locked |
Investor details for TrialScope
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by TrialScope
TrialScope has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Clinical Trial Connect and PharmaCM.
Investment portfolio details for TrialScope
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Patients are matched to clinical trials through an online platform.
|
Locked | Locked | 2017 | Locked | |
|
Compliance and content management solutions for life sciences are provided.
|
Locked | Locked | 2007 | Locked |
Complete acquisition details for TrialScope
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - TrialScope
Detailed financials for TrialScope
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Trialscope Comparisons
Peer comparison for TrialScope
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of TrialScope
TrialScope operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Envision Pharma Group, MetricStream, Octagon Research, Qualio and MasterControl, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Compliant global publication planning is offered for life sciences.
|
|
| Locked | Locked | Locked |
Cloud-based regulatory solutions are provided for financial institutions.
|
|
| Locked | Locked | Locked |
Clinical and regulatory information management software is provided for pharmaceuticals.
|
|
| Locked | Locked | Locked |
Web-based quality management software is delivered for life sciences firms.
|
|
| Locked | Locked | Locked |
Provider of governance, risk and compliance solutions for life sciences industries
|
|
| Locked | Locked | Locked |
Legit is recognized as a pioneer in privacy and data protection, offering innovative RegTech solutions.
|
Detailed competitors of TrialScope
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Trialscope
Complete news archive for TrialScope
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about TrialScope
TrialScope was founded in 2012 and raised its 1st funding round 2 years after it was founded.
TrialScope is headquartered in Jersey City, United States. It is registered at Jersey City, New Jersey, United States.
TrialScope is a funded company, having raised a total of $27.97M across 5 funding rounds to date.
TrialScope was founded in 2012 and is based in Jersey City, United States. Cloud-based platforms are offered by the company to clinical trial sponsors in the pharmaceutical sector. The PharmaCM solution is used for authoring, reviewing, editing, approving, and publishing trial application and disclosure data. Integrated services are provided that address registration, transparency reporting, disclosure requirements, and regulatory compliance.
TrialScope's top competitors include Envision Pharma Group, Qualio and MasterControl.
TrialScope offers Citeline Clinical, Pink Sheet, TrialScope Disclose, and TrialScope Intelligence.
TrialScope has made 2 acquisitions, including Clinical Trial Connect, and PharmaCM.
TrialScope has 5 investors. Key investors include Pharma Intelligence, Bridge Capital, Edison Partners, Dublin Capital Partners, and NewSpring Capital.